文献速递腹部技术与安全CT

评估定量CT灌注参数在鉴别肝细胞癌与其他肝脏肿瘤中的作用

Evaluating the role of quantitative computed tomography perfusion parameters in differentiating hepatocellular carcinoma from other hepatic neoplasms.
PubMed 文献 · Abdom Radiol (NY) · 2024-11-25

48例疑似肝脏病变患者行CT灌注成像,评估肿瘤及邻近正常肝组织的灌注参数。肝动脉灌注、门静脉灌注、肝灌注指数、血流量、血容量、平均通过时间和达峰时间在肝细胞癌与其他肝脏肿瘤间均有统计学差异(P<0.05),其中血容量曲线下面积最大为0.938,阈值8.3 ml/100 ml/min时敏感度96.6%、特异度80%。

要点

  • 血容量鉴别肝细胞癌与其他肝脏肿瘤的曲线下面积最大(0.938),阈值8.3 ml/100 ml/min时敏感度96.6%、特异度80%。
  • 肝动脉灌注、门静脉灌注、肝灌注指数、血流量、血容量、平均通过时间和达峰时间在肝细胞癌与其他肝脏肿瘤间均有统计学差异(P<0.05)。
  • 肝灌注指数、血流量、血容量和达峰时间在鉴别富血供转移瘤与肝细胞癌中有统计学差异。

核心结论

  • CT灌注提供了一种定量、无创的方法来鉴别肝细胞癌与其他肝脏肿瘤,效能较高;当常规三期增强CT无法将病灶定性为肝细胞癌且活检不可行时,可作为解决问题的工具。

研究设计与样本

  • 48例疑似肝脏病变患者行CT灌注成像,采用后处理软件评估肿瘤内及邻近正常肝组织的灌注参数,参考标准为肝细胞癌与其他肝脏肿瘤的鉴别。

诊断标准与关键数值

  • 血容量鉴别肝细胞癌与其他肝脏肿瘤的曲线下面积为0.938,阈值8.3 ml/100 ml/min时敏感度96.6%、特异度80%。
  • 肝动脉灌注、门静脉灌注、肝灌注指数、血流量、血容量、平均通过时间和达峰时间在肝细胞癌与其他肝脏肿瘤间均有统计学差异(P<0.05)。
  • 肝灌注指数、血流量、血容量和达峰时间在鉴别富血供转移瘤与肝细胞癌中有统计学差异。
  • 肝动脉灌注、肝灌注指数、血流量、血容量和达峰时间在鉴别肝细胞癌与乏血供转移瘤中有统计学差异。
  • 血流量和血容量在鉴别富血供与乏血供转移瘤中有统计学差异;肝动脉灌注、门静脉灌注、肝灌注指数、血流量、血容量和达峰时间在鉴别肝细胞癌与肝内胆管癌中有统计学差异。

临床应用与阅片要点

  • 当常规三期增强CT因特征重叠、活检禁忌(尤其多发病灶伴肝硬化或腹水)或MRI不可用/不可行而难以无创鉴别肝细胞癌与其他肝脏肿瘤时,CT灌注可提供定量参数辅助鉴别。
  • 血容量阈值8.3 ml/100 ml/min时鉴别肝细胞癌与其他肝脏肿瘤的敏感度96.6%、特异度80%,曲线下面积0.938。
  • 肝灌注指数、血流量、血容量和达峰时间有助于鉴别富血供转移瘤与肝细胞癌;肝动脉灌注、肝灌注指数、血流量、血容量和达峰时间有助于鉴别肝细胞癌与乏血供转移瘤。
  • 肝动脉灌注、门静脉灌注、肝灌注指数、血流量、血容量和达峰时间有助于鉴别肝细胞癌与肝内胆管癌;血流量和血容量有助于鉴别富血供与乏血供转移瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Differentiating the various liver tumors is pivotal due to distinct treatments and prognoses. Sometimes, it is difficult to accurately differentiate hepatocellular carcinoma (HCC) from other hepatic neoplasms non-invasively because of overlap in the triple-phase contrast-enhanced computed tomography (CECT) features, contraindication of an invasive biopsy, particularly in multifocal lesions with cirrhosis or ascites or when an MRI is unavailable or not feasible.

OBJECTIVES: To assess the utility of CT perfusion (CTP) parameters in differentiating HCC from other hepatic neoplasms.

METHODS: Forty-eight patients with suspicious liver lesions underwent CTP imaging. Perfusion parameters were assessed within the tumor and the adjacent normal liver using the post-processing software. Statistical significance (p-value), sensitivity, and specificity value of the individual parameters were assessed. The receiver operating characteristic (ROC) curve analysis was done to threshold values of the parameters.

RESULTS: The mean values of perfusion parameters like HAP (hepatic arterial perfusion), PVP (portal venous perfusion), HPI (hepatic perfusion index), BF (blood flow), BV (blood volume), MTT (mean transit time), and TTP (time to peak) were statistically significant (p-value < 0.05) between HCC and other hepatic neoplasms. Among the parameters, BV had the greatest AUC of 0.938. With a threshold value of 8.3 ml/100 ml/min, the sensitivity and specificity were 96.6% and 80%, respectively, in distinguishing HCC from other hepatic neoplasms. HPI, BF, BV, and TTP were statistically significant in differentiating hypervascular metastases from HCCs. HAP, HPI, BF, BV, and TTP were statistically significant in differentiating HCC from hypovascular metastases. BF and BV were significant in differentiating hypervascular from hypovascular metastases. HAP, PVP, HPI, BF, BV, and TTP were statistically significant in differentiating HCCs from intrahepatic cholangiocarcinomas.

CONCLUSION: CTP provides a quantitative, non-invasive method to differentiate HCC from other hepatic neoplasms with high efficacy. It can be a problem-solving tool when a conventional CECT scan cannot characterize a lesion as HCC, where biopsy is not feasible.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Mohakud S, Sreejith V, Bag ND, et al. Evaluating the role of quantitative computed tomography perfusion parameters in differentiating hepatocellular carcinoma from other hepatic neoplasms. Abdom Radiol (NY). 2024. PMID: 39585378. doi:10.1007/s00261-024-04688-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。